Pharma listed cos: FY26 profits surge 28pc to Rs42.2bn YoY
Profitability of Pakistan’s listed pharmaceutical sector increased 28 percent year-on-year (YoY) to Rs42.2 billion in FY26, mainly supported by price-led growth and lower finance costs, according to a Research report issued. However, sector earnings declined 2 percent YoY and 26 percent quarter-on-quarter (QoQ) in 4QFY26, primarily due to the loss posted by The Searle Company Limited (SEARL) during the quarter. Excluding SEARL, sector profitability increased 6 percent YoY but declined 4 percent QoQ to Rs9.3 billion in 4QFY26.